ArticleOpen forum infectious diseases2022

Clarithromycin-Rifampin-Based Treatment for Nontuberculous Mycobacteria Infections in Immunocompromised Patients who Require Concomitant CYP-Metabolized Medications.

Isabel H Gonzalez-Bocco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.